Innovations in Biologics and Biosimilars
Innovations in Biologics and Biosimilars
Biologics are complex, biologically derived medicines used to treat various conditions, including autoimmune diseases, cancers, and genetic disorders. Biosimilars are biologic products that are highly similar to an already-approved reference biologic in terms of structure, efficacy, and safety but are typically offered at a lower cost. Both biologics and biosimilars are driving innovations in medical treatment and making previously expensive therapies more accessible.
Related Conference of Innovations in Biologics and Biosimilars
Innovations in Biologics and Biosimilars Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy